Fund shareholders of Ryvu Therapeutics SA
ISIN PLSELVT00013 · Poland · LEI 2594003WO9Q9HHAFL031
- Fund shareholders
- 3
- Of which ETFs
- 2 1 other fund
- Value held
- 89.1K $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 10,061 | 61K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 3,875 | 25.7K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Europe ETF SPDR INDEX SHARES FUNDS | 390 | 2.4K $ | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 0.01 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Europe ETF SPDR INDEX SHARES FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 3 | +1 | 14,326 | +36.8 % |
| 2026Q1 | 2 | 0 | 10,475 | +4.5 % |
| 2025Q4 | 2 | +1 | 10,020 | +2,285.7 % |
| 2025Q3 | 1 | 0 | 420 | -41.4 % |
| 2025Q2 | 1 | 0 | 717 | +67.1 % |
| 2025Q1 | 1 | 0 | 429 | +41.6 % |
| 2024Q4 | 1 | 0 | 303 | +46.4 % |
| 2024Q3 | 1 | 0 | 207 | +9.5 % |
| 2024Q2 | 1 | 0 | 189 | +12.5 % |
| 2024Q1 | 1 | 0 | 168 | -9.7 % |
| 2023Q4 | 1 | 186 |
Cite this page
Titelia. "Fund shareholders of Ryvu Therapeutics SA". https://titelia.com/en/stocks/ryvu-therapeutics-sa-PLSELVT00013